Main Page Content

​​​​ ​
  
Details
  
  
  
  
  
  
  
  
BlueRock bought
BlueRock Therapeutics, a global leader in stem-cell research and co-founded by UHN researchers, has been fully acquired by Bayer AG.
9/30/2015 11:00 AM10/14/2015 12:00 AM10Bayer Acquires BlueRock TherapeuticsBlueRock TherapeuticsBlueRock Therapeutics
Listen up
At Toronto Rehab, students are being trained to put aside their agendas and use deep listening to help patients achieve their rehab goals. 
9/30/2015 10:00 AM10/14/2015 12:00 AM20Learning to listen for the stories patients have to tellSpeech-languageSpeech-language
Cushioning recovery

UHN Volunteer Resources’ Patient Pillow Program offers physical and emotional comfort after cardiac surgery.

9/30/2015 11:00 AM10/14/2015 12:00 AM30Heart-shaped pillows cushion recovery for cardiac patientsMichaelMichael
Innovative partnership
Krembil researchers teaming up with MaRS Innovation to develop a new treatment for Rett syndrome.
9/28/2015 11:33 PM10/12/2015 12:00 AM40A partnership to make new medicinesDr. James Eubanks (L) and Dr. Mark ReedDr. James Eubanks (L) and Dr. Mark Reed
Better learning
UHN’s Emergency Department Simulation Committee is improving patient safety with simulation exercises
9/29/2015 12:00 AM10/12/2015 12:00 AM50‘It’s a better learning experience for everyone’simulation exercisessimulation exercises
Congrats, graduates!
UHN's Emerging Leaders Program is designed to help employees prepare for the next step in their careers
9/30/2015 11:00 AM10/14/2015 12:00 AM60Program ‘fostered a new type of learning for me’2018-19 Emerging Leaders Program2018-19 Emerging Leaders Program